Загрузка...
A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancer
BACKGROUND: Immune checkpoint inhibitors (ICIs) represent a breakthrough in cancer treatment. However, they have rarely been used to treat biliary tract cancer (BTC). In the current study, we aimed to evaluate and compare the efficacy and safety of anti-programmed cell death-1 (PD-1) therapy used al...
Сохранить в:
| Опубликовано в: : | J Gastrointest Oncol |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7807271/ https://ncbi.nlm.nih.gov/pubmed/33457011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-562 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|